John Hoekman - 22 Dec 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC

Role
Chief Scientific Officer
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Issuer symbol
N/A
Transactions as of
22 Dec 2021
Net transactions value
+$32,800
Form type
4
Filing time
23 Dec 2021, 15:50:37 UTC
Previous filing
26 Jul 2021
Next filing
28 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMPL Common Stock Options Exercise $32,800 +20,000 +18% $1.64 128,221 22 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Options Exercise $0 +20,000 $0.000000* 0 22 Dec 2021 Common Stock 20,000 $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested and exercisable.